Pharmacokinetic Profile of the Somatostatin Analogue Lanreotide in Individuals with Chronic Hepatic Insufficiency

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.45, Iss.10, 2006-01, pp. : 1003-1011

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic evaluation of lanreotide

By Hu Miao Tomlinson Brian

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 10, 2010-10 ,pp. : 1301-1312

Informa Healthcare

Access to resources Recommend Favorite

Down-Regulation of Hepatic CYP3A in Chronic Renal Insufficiency

By Rege B. Krieg R. Gao N. Sarkar M.A.

Pharmaceutical Research, Vol. 20, Iss. 10, 2003-10 ,pp. : 1600-1606

Springer Publishing Company

Access to resources Recommend Favorite

Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile

Current Pharmaceutical Design, Vol. 22, Iss. 28, 2016-09 ,pp. : 4386-4397

Bentham Science Publishers

Access to resources Recommend Favorite

Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC)

By Mitsogiannis Iraklis C Skolarikos Andreas Deliveliotis Charalambos

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 3, 2009-02 ,pp. : 493-501

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Profile of Posaconazole

By Li Yanjun

Clinical Pharmacokinetics, Vol. 49, Iss. 6, 2010-06 ,pp. : 379-396

Adis International

Access to resources Recommend Favorite